Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iratumumab (MDX-060), a human anti-CD30 IgG1κ monoclonal antibody, inhibits the growth of CD30-expressing tumor cells and is utilized in the research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Iratumumab (MDX-060), a human anti-CD30 IgG1κ monoclonal antibody, inhibits the growth of CD30-expressing tumor cells and is utilized in the research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) [1]. |
Molecular Weight | N/A |
CAS No. | 640735-09-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iratumumab 640735-09-7 inhibitor inhibit